Development of Controlled Release Captopril Granules Coated with Ethylcellulose and Methylcellulose by Fluid Bed Dryer

REFERENCES

• Agnihotri S. A., Aminabhavi T. M. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J. Control Rel. 2004; 96: 245–259
   PubMed Web of Science ®Google Scholar
• Backer R. W., Lonsdale H. K. Controlled release: mechanism and rates. Controlled Release of Biological Active Agents, A. C. Tanquary, R. E. Lacey. Plenum Press, New York 1993
   Google Scholar
• Costa P., Lobo J. M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001; 13: 123–133
   PubMed Web of Science ®Google Scholar
• Efentakis M., Vlachou M. Evaluation of high molecular weight poly (oxyethylene) (Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules. Pharm. Devel. Technol. 2000; 5: 339–346
   PubMed Web of Science ®Google Scholar
• Florence A. T., Attwood D. Princípios Físico-Químicos em Farmácia, 3rd ed. Editora da Universidade de São Paulo, São PauloBrazil 2003
   Google Scholar
• Franklin M. E., Addison R. S., Baker P. V., et al. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography mass spectrometry and its application to pharmacokinetic studies. J. Chromatogr. 1998; 705: 47–54
   Web of Science ®Google Scholar
• Giron D. Characterization of salts of drug substances. J. Therm. Anal. Calorim. 2003; 73: 441–457
   Web of Science ®Google Scholar
• Heng P. W. S., Chan L. W., Tang E. S. K. Use of swirling airflow to enhance coating performance of bottom spray fluid bed coaters. Int. J. Pharm. 2006; 327: 26–35
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid dispersed in solid matrices. J. Pharm. Sc. 1963; 52: 1145–1149
   PubMed Web of Science ®Google Scholar
• Hixson A. W., Crowell J. H. Dependence of reaction velocity upon surface and agitation. Ind. Eng. Chem. 1931; 23: 923–931
   Google Scholar
• Ho H. O., Wang H. Y., Sheu M. T. The evaluation of granulated excipients as matrix material for controlled delivery of captopril. J. Control. Rel. 1997; 49: 243–251
   Web of Science ®Google Scholar
• Jinno J., Kamada N., Miyake M., et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control Rel. 2006; 111: 56–64
   PubMed Web of Science ®Google Scholar
• Kaul D., Nguyen T. N., Venkataram S. Crystal habit modifications and altered tabletting characteristics. Int. J. Pharm. 1992; 88: 345–350
   Google Scholar
• Khattab I. S., Abdel-Rahman S., Khidr S., et al. Development and optimization of sustained-release captopril tablets and capsules. Egypt J. Biotechnol. 2001; 10: 32–445
   Google Scholar
• Korsmeyer R. W., Gurny R., Doelker E., et al. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
   Web of Science ®Google Scholar
• Kristl A., Srčič S., Vrečcer F., et al. Polymorphism and pseudopolymorphism: influencing the dissolution properties of guanine derivative acyclovir. Int. J. Pharm. Sci. 1996; 139: 231–235
   Web of Science ®Google Scholar
• Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 1972; 24: 979–981
   PubMed Web of Science ®Google Scholar
• Markovich R. J., Evans C. A., Coscolluela C. B., et al. Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation. J. Pharm. Biomed. Anal. 1997; 16: 661–673
   PubMed Web of Science ®Google Scholar
• Matharu R. S., Sanghavi N. M. Novel drug delivery system for captopril. Drug Dev. Ind. Pharm. 1992; 18: 1567–1574
   Web of Science ®Google Scholar
• Munday D. L., Cox P. L. Compressed xanthan and karaya gum matrices hydration, erosion and drug release mechanisms. Int. J. Pharm. 2000; 203: 179–192
   PubMed Web of Science ®Google Scholar
• Nixon J. R. Release characterization of microcapsules. Biomedical Applications of Microcapsulation, F. Lim. CRC Press, Boca Raton, FL 1983
   Google Scholar
• Nur A. O., Zhang J. S. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev. Ind. Pharm. 2000; 26: 965–969
   PubMed Web of Science ®Google Scholar
• Pastrana Y. C., Rivera A. B., Enrique T. E., et al. Caracterización farmacocinética de formulaciones orales de liberación sostenida. Factores que influyen en el perfil farmacocinético. Acta Farm. Bonaerense 2000; 19: 25–34
   Google Scholar
• Petrillo E. W., Ondetti M. A. Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions. Med. Res. Rev. 1982; 2: 1–41
   PubMed Web of Science ®Google Scholar
• Purvis T., Vaughn J. M., Rogers T. L., et al. Cryogenic liquids, nanoparticles, and microencapsulation. Int. J. Pharm. 2006; 324: 43–50
   PubMed Web of Science ®Google Scholar
• Ranga R., Devi K. D., Buri P. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 1988; 14: 2299–2320
   Web of Science ®Google Scholar
• Regoli D., Park W. K., Rioux F. Pharmacology of angiotensin. Pharmacol Rev. 1974; 26: 69–123
   PubMed Web of Science ®Google Scholar
• Ribeiro W., Muscará M. N. Características farmacocinéticas de antagonistas de cálcio, inibidores da ECA e antagonistas de angiotensina II em humanos. Rev Bras de Hipertens. 2001; 8: 114–124
   Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control Rel. 1987a; 5: 23–36
   Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control Rel. 1987b; 5: 37–42
   Google Scholar
• Rhodes C. T., Porter S. C. Coatings for controlled-release drug delivery systems. Drug Dev. Ind. Pharm. 1998; 24: 1139–1154
   PubMed Web of Science ®Google Scholar
• Romankiewicz J. A., Brogden R. N., Heel R. C., et al. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs 1983; 25: 6–40
   PubMed Web of Science ®Google Scholar
• Royce A. L. S., Weaver M., Shah U. In vivo in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2′-O-methyladenosine. J. Control. Rel. 2004; 97: 79–90
   PubMed Web of Science ®Google Scholar
• Saks S. R., Gardner L. B. The pharmacoeconomic value of controlled-release dosage forms. J. Control Rel. 1997; 48: 237–242
   Web of Science ®Google Scholar
• Seta Y., Higuchi F., Kawahara Y., et al. Design and preparation of captopril sustained release and dosage forms and their biopharmaceutical properties. Int. J. Pharm. 1988; 41: 245–254
   Web of Science ®Google Scholar
• Singh J., Robinson D. H. Controlled release captopril microcapsules: effect of non-ionic surfactants on release from ethyl cellulose microcapsules. J. Microencapsul. 1988; 5: 129–137
   PubMed Web of Science ®Google Scholar
• Storpirts S., Oliveira P. G., Rodrigues D., et al. Considerações biofarmacêuticas relevantes na fabricação de medicamentos genéricos: fatores que afetam a dissolução e a absorção de fármacos. Rev. Bras. Cien. Farm. 1999; 35: 1–11
   Google Scholar
• Stulzer H. K., Silva M. A. S. Estudo de estabilidade de grânulos revestidos e comprimidos contendo captopril. Acta Farm. Bonaerense 2006; 25: 497–504
   Google Scholar
• Vudathala G. K., Rogers J. A. Dissolution of fludrocortisone from biphasic polymers hydrogels. J. Control. Rel. 1995; 34: 185–192
   Web of Science ®Google Scholar
• Wagner J. G. Interpretation of percentage dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969; 58: 1253–1257
   PubMed Web of Science ®Google Scholar
• Wei C., Thau M. Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 1996; 127: 261–272
   Google Scholar
• Wilding I. R., Davis S. S., Bakhshaee M., et al. Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm. Res. 1992; 9: 654–657
   PubMed Web of Science ®Google Scholar